Steven Coutre

Publication Details

  • Acute Lymphoblastic Leukemia JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK Alvarnas, J. C., Brown, P. A., Aoun, P., Ballen, K. K., Bellam, N., Blum, W., Boyer, M. W., Carraway, H. E., Coccia, P. F., Coutre, S. E., Cultrera, J., Damon, L. E., DeAngelo, D. J., Douer, D., Frangoul, H., Frankfurt, O., Goorha, S., Millenson, M. M., O'Brien, S., Petersdorf, S. H., Rao, A. V., Terezakis, S., Uy, G., Wetzler, M., Zelenetz, A. D., Naganuma, M., Gregory, K. M. 2012; 10 (7): 858-913

    Abstract:

    The inaugural NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for acute lymphoblastic leukemia (ALL) were developed as a result of meetings convened by a multi-disciplinary panel of experts in 2011. These NCCN Guidelines provide recommendations on the diagnostic evaluation and workup for ALL, risk assessment, risk-stratified treatment approaches based on the Philadelphia chromosome status and age (adults vs. adolescents/young adults), assessment of minimal residual disease, and supportive care considerations. It is recommended that patients be treated at specialized centers with expertise in the management of ALL.

    View details for Web of Science ID 000306303900009

    View details for PubMedID 22773801

Stanford Medicine Resources:

Footer Links: